208 related articles for article (PubMed ID: 15972239)
1. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma.
Wersäll PJ; Blomgren H; Lax I; Kälkner KM; Linder C; Lundell G; Nilsson B; Nilsson S; Näslund I; Pisa P; Svedman C
Radiother Oncol; 2005 Oct; 77(1):88-95. PubMed ID: 15972239
[TBL] [Abstract][Full Text] [Related]
2. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
Svedman C; Sandström P; Pisa P; Blomgren H; Lax I; Kälkner KM; Nilsson S; Wersäll P
Acta Oncol; 2006; 45(7):870-5. PubMed ID: 16982552
[TBL] [Abstract][Full Text] [Related]
3. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma.
Wersäll PJ; Blomgren H; Pisa P; Lax I; Kälkner KM; Svedman C
Acta Oncol; 2006; 45(4):493-7. PubMed ID: 16760190
[No Abstract] [Full Text] [Related]
4. Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney.
Svedman C; Karlsson K; Rutkowska E; Sandström P; Blomgren H; Lax I; Wersäll P
Acta Oncol; 2008; 47(8):1578-83. PubMed ID: 18607859
[TBL] [Abstract][Full Text] [Related]
5. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience.
Nomiya T; Tsuji H; Hirasawa N; Kato H; Kamada T; Mizoe J; Kishi H; Kamura K; Wada H; Nemoto K; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):828-33. PubMed ID: 18374507
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.
Nagata Y; Takayama K; Matsuo Y; Norihisa Y; Mizowaki T; Sakamoto T; Sakamoto M; Mitsumori M; Shibuya K; Araki N; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1427-31. PubMed ID: 16169670
[TBL] [Abstract][Full Text] [Related]
7. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiotherapy for the treatment of pituitary adenomas.
Selch MT; Gorgulho A; Lee SP; Mattozo C; Solberg TD; Agazaryan N; Desalles AA
Minim Invasive Neurosurg; 2006 Jun; 49(3):150-5. PubMed ID: 16921455
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
11. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy.
Lin CS; Jen YM; Chiu SY; Hwang JM; Chao HL; Lin HY; Shum WY
Jpn J Clin Oncol; 2006 Apr; 36(4):212-7. PubMed ID: 16613896
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity.
Henzel M; Gross MW; Hamm K; Surber G; Kleinert G; Failing T; Strassmann G; Engenhart-Cabillic R
Strahlenther Onkol; 2006 Jul; 182(7):382-8. PubMed ID: 16826356
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients.
Jereczek-Fossa BA; Kowalczyk A; D'Onofrio A; Catalano G; Garibaldi C; Boboc G; Vitolo V; Leonardi MC; Cambria R; Orecchia R
Strahlenther Onkol; 2008 Jan; 184(1):36-40. PubMed ID: 18188521
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma.
Lee J; Hodgson D; Chow E; Bezjak A; Catton P; Tsuji D; O'Brien M; Danjoux C; Hayter C; Warde P; Gospodarowicz MK
Cancer; 2005 Nov; 104(9):1894-900. PubMed ID: 16177996
[TBL] [Abstract][Full Text] [Related]
16. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma.
Hoyer M; Roed H; Sengelov L; Traberg A; Ohlhuis L; Pedersen J; Nellemann H; Kiil Berthelsen A; Eberholst F; Engelholm SA; von der Maase H
Radiother Oncol; 2005 Jul; 76(1):48-53. PubMed ID: 15990186
[TBL] [Abstract][Full Text] [Related]
17. Image-guided helical Tomotherapy for treatment of spine tumors.
Kim B; Soisson ET; Duma C; Chen P; Hafer R; Cox C; Cubellis J; Minion A; Plunkett M; Mackintosh R
Clin Neurol Neurosurg; 2008 Apr; 110(4):357-62. PubMed ID: 18295971
[TBL] [Abstract][Full Text] [Related]
18. Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma.
Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):797-802. PubMed ID: 15936562
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiotherapy for the treatment of nonacoustic schwannomas.
Hamm KD; Gross MW; Fahrig A; Surber G; Henzel M; Kleinert G; Grabenbauer GG; Engenhart-Cabillic R
Neurosurgery; 2008 May; 62(5 Suppl):A29-36; discussion A36. PubMed ID: 18580778
[TBL] [Abstract][Full Text] [Related]
20. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma.
Choi BO; Jang HS; Kang KM; Lee SW; Kang YN; Chai GY; Choi IB
Jpn J Clin Oncol; 2006 Mar; 36(3):154-8. PubMed ID: 16520355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
